- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Teduglutide – July 2018
Teduglutide; Powder for injection 5 mg with diluent; Revestive®
Last updated
26 October 2018